Determination of temozolomide in human plasma and urine by high-performance liquid chromatography after solid-phase extraction
Data up to Jan 2025
Total Citations Per Year
Abstract
References (8)
Analytical methods validation: Bioavailability, bioequivalence and pharmacokinetic studies
1991 • 585 citations
Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856)
1992 • 483 citations
Antitumor activity and pharmacokinetics in mice of 8-carbamoyl-3-methyl-imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (CCRG 81045; M & B 39831), a novel drug with potential as an alternative to dacarbazine.
1987 • 386 citations
Inactivation of O6-alkylguanine-DNA alkyltransferase in human peripheral blood mononuclear cells by temozolomide
1994 • 87 citations
Characterisation of urinary metabolites of temozolomide in humans and mice and evaluation of their cytotoxicity
1990 • 65 citations
Antitumour imidazotetrazines
1985 • 15 citations
The relevance of pharmacology in clinical oncology practice
1993 • 6 citations
Apoptosis
1994 • 3 citations